About
Elizabeth teaches yoga with the intention that students leave feeling better than when they first entered the class. Her belief is that through the experience of the movement of the body, it is possible for us to develop a deep awareness of ourselves. We can ask questions such as…how can we move to feel better? How do you sit on the floor? How do you even sit still in today’s world of “Let’s go!”? With a bit of humor, she has taught yoga to help students get to that bit of peace that can be elusive, all the while having a bit of fun.
The first yoga classes she took were in 1995, but it wasn’t anything that drew her in. Then, her friend talked her into an Ashtanga Yoga course that was held in her college on the basketball courts – that was the entry into her passion for the practice. She received her first yoga certification in 2000 and has been RYT500 since 2008. Elizabeth has taught classes at gyms, the University of Arizona, the Arizona School for the Deaf and Blind, and yoga studios. She believes that yoga can enhance many aspects of our lives and that by simply practicing when and where you can is key.
Elizabeth is also a scientist and holds a Ph.D. in Molecular and Cellular Biology. In addition to teaching yoga, she also develops Cancer Diagnostics in the tech world to continue to pursue her passion in creating products and methods that help cancer patients. She lives with her dog Odelle, and can be found around town inevitably driving with him with his head out the window.
Elizabeth Little, ERTY 500 CV
Certifications/Registration
Yoga Alliance Registered Yoga Teacher 500 (2008) – Registration is current.
Joy of Yoga 300 (2024)
Anusara Yoga Certification (2008)
Hatha Yoga Certification (2000)
Public Teaching
Breathe Together Yoga, 2021-Present
Currently teaching Basics and will resume teaching Foundations in the beginning of 2025.
Conducted the workshop Routine to Ritual to help students establish their own personal practice in Aug. 2024
RedDot Fitness, 2019-Present
Currently teaching Nervous System Reset with an alternating emphasis on hips and shoulders.
Yoga Oasis (Central, East, and Downtown locations), 1999-2012
Taught and substituted yoga classes at all levels, led workshops, and assisted teacher trainings. Comfortable with all levels of students.
Metro Fitness/Gold’s Gym, 2000-2007
Saturday morning Power Yoga class that included students of all levels practice, both philosophically and physically.
Co-taught the class for the first 5 years by alternating weekends to support the original teacher that also had family responsibilities.
Arizona School for the Deaf and Blind, 2002-2004
Volunteered with two other yoga instructors to teach a weekly yoga class. This incredible experience included working with children of all abilities with varying levels of sight, hearing, learning, and physical challenges.
University of Arizona, 2000-2002
Taught a bi-weekly yoga class to University of Arizona students at the Student Recreation Center. Classes included students of all levels.
Marfa, Texas Workshop, 2010
Invited to and led a two-day workshop in Marfa, Texas at Fort D.A. Russell. The workshop included emphases on forward folds, backbends, arm balances, and inversions.
Elizabeth Little, PhD CV
INNOVATION LEAD
Healthcare Product Developer with deep expertise on cancer research and diagnostics. Offers team leadership and project management capabilities. Creates and sustains connections between assay, hardware engineering, software engineering and marketing groups. Experienced at presenting complex ideas to diverse internal and external audiences. Recognized for being solution-driven and a mentor. Projects completed include six U.S. FDA 510(k) clearances and six indications for use that received CE-IVD Marks.
EDUCATION
Ph.D. - Molecular and Cellular Biology, University of Arizona, Tucson, AZ Focus: Characterization of cell cycle arrest pathways following DNA damage.
B.S. - Biochemistry and Cell Biology, University of California, San Diego, CA Focus: Phylogenic and computational analysis of molecular evolution.
CAREER PROGRESSION
Roche Information Solutions
Innovation Lead - Santa Clara, CA (2024-present)
Contributes to the Innovation Management program, collaborating with cross-functional teams to support strategic initiatives in product development and organizational improvement. Engages with Key Opinion Leaders and customers to inform market-driven product strategies while assisting in enhancing internal processes and forward- thinking proposals.
Head of Innovation Delivery - Santa Clara, CA (2021-2024) Led the Innovation Management contribution of the development and execution of the Providers Insights Neurology for clinical use program. Fostered strong business connections with external key opinion leaders and internal cross- functional experts to support a culture of innovation. Supported the development and implementation of the innovation process to drive key results for the business. Co-led the creation and management of the program funnel management system for Innovation Management team. and is co-leading the drive for the creation of strategic insights for future Neurology funnel initiatives.
Pre-Development Program Director - Belmont, CA (2019- 2021)Drove a newly formed Pre-development program that brought structure and visibility to early stage product initiatives. Monthly meetings highlighted accomplishments and blockers of project teams to senior management in addition to enabling the opportunity for decision making by leadership on whether a project would continue. Drove the development of a population health analytics platform in collaboration with data scientists, epidemiologists, and software engineers during the COVID-19 pandemic to support an RIS COVID-19 patient software application, RDS leadership decision making, and Pharma clinical trial placements.
Project Leader - Belmont, CA (2018- 2019)
Led both a cross-functional and international team to the successful launch of two on market clinical decision support software applications to support clinical oncology teams. One application enables clinical teams to rapidly match patients with clinical trials based on their unique patient record. The second application searches for patient relevant research publications that can be used to enable patient care. Team members were located in Belmont, California, Poznan and Warsaw, Poland, and Basel, Switzerland.
Guardant Health, Inc. 2016-2017, Director, IVD Product Development
Led cross-functional project teams that developed NGS in vitro diagnostics systems. Managed the activities and performance of both direct reports and contractors involved in development projects. Delivered strategic project planning and management to in vitro diagnostic portfolio.
Roche Tissue Diagnostics 2008-2016
Project Leader - Mountain View, CA (2012- 2016)
Directed digital pathology product solutions that assist physicians and pathologists in diagnosing cancer. The technology plays a key role in enabling access to multiple pathologist consultations via the internet, quantitative tissue image analysis, and future multiplex tissue assays. Managed teams in Tucson, AZ and Mountain View, CA in the development of companion diagnostics and digital pathology imaging algorithms. Oversaw clinical trials and managed regulatory submissions for medical devices. Engaged in the development of in vitro diagnostic systems.
Supervisor, Systems Integration Tucson, AZ (2011-2012)
Provided leadership for a technical team engaged in delivering a complex technology and vendor assessment for digital pathology’s next generation hardware platform. Drove, authored and delivered feasibility plan and report that included risk assessment. Achieved design goal milestone on time and within budget.
Senior Scientist, Systems Integration, Tucson, AZ (2008-2011)
Sub-team lead for one of five modules in a tissue diagnostics platform. Spearheaded an effort to increase the reliability of the module and improve customer experience. Engaged in project management, prototype design, design execution, verification and validation testing. Conducted cross-functional communication with software engineers, hardware engineers, marketing managers, global technical support staff and key executives. Communicated and coordinated module changes, and presented final design review.
PATENTS
The first yoga classes she took were in 1995, but it wasn’t anything that drew her in. Then, her friend talked her into an Ashtanga Yoga course that was held in her college on the basketball courts – that was the entry into her passion for the practice. She received her first yoga certification in 2000 and has been RYT500 since 2008. Elizabeth has taught classes at gyms, the University of Arizona, the Arizona School for the Deaf and Blind, and yoga studios. She believes that yoga can enhance many aspects of our lives and that by simply practicing when and where you can is key.
Elizabeth is also a scientist and holds a Ph.D. in Molecular and Cellular Biology. In addition to teaching yoga, she also develops Cancer Diagnostics in the tech world to continue to pursue her passion in creating products and methods that help cancer patients. She lives with her dog Odelle, and can be found around town inevitably driving with him with his head out the window.
Elizabeth Little, ERTY 500 CV
Certifications/Registration
Yoga Alliance Registered Yoga Teacher 500 (2008) – Registration is current.
Joy of Yoga 300 (2024)
Anusara Yoga Certification (2008)
Hatha Yoga Certification (2000)
Public Teaching
Breathe Together Yoga, 2021-Present
Currently teaching Basics and will resume teaching Foundations in the beginning of 2025.
Conducted the workshop Routine to Ritual to help students establish their own personal practice in Aug. 2024
RedDot Fitness, 2019-Present
Currently teaching Nervous System Reset with an alternating emphasis on hips and shoulders.
Yoga Oasis (Central, East, and Downtown locations), 1999-2012
Taught and substituted yoga classes at all levels, led workshops, and assisted teacher trainings. Comfortable with all levels of students.
- Weekly classes were Intro to Yoga, Basics, Yoga Hour, and Advanced.
- Workshops included Arm Balances (2 day), Anusuara 101 (6 days), and Yamas and Niyamas (2 days).
- Assisted studio owner with teacher trainings.
Metro Fitness/Gold’s Gym, 2000-2007
Saturday morning Power Yoga class that included students of all levels practice, both philosophically and physically.
Co-taught the class for the first 5 years by alternating weekends to support the original teacher that also had family responsibilities.
Arizona School for the Deaf and Blind, 2002-2004
Volunteered with two other yoga instructors to teach a weekly yoga class. This incredible experience included working with children of all abilities with varying levels of sight, hearing, learning, and physical challenges.
University of Arizona, 2000-2002
Taught a bi-weekly yoga class to University of Arizona students at the Student Recreation Center. Classes included students of all levels.
Marfa, Texas Workshop, 2010
Invited to and led a two-day workshop in Marfa, Texas at Fort D.A. Russell. The workshop included emphases on forward folds, backbends, arm balances, and inversions.
Elizabeth Little, PhD CV
INNOVATION LEAD
Healthcare Product Developer with deep expertise on cancer research and diagnostics. Offers team leadership and project management capabilities. Creates and sustains connections between assay, hardware engineering, software engineering and marketing groups. Experienced at presenting complex ideas to diverse internal and external audiences. Recognized for being solution-driven and a mentor. Projects completed include six U.S. FDA 510(k) clearances and six indications for use that received CE-IVD Marks.
EDUCATION
Ph.D. - Molecular and Cellular Biology, University of Arizona, Tucson, AZ Focus: Characterization of cell cycle arrest pathways following DNA damage.
B.S. - Biochemistry and Cell Biology, University of California, San Diego, CA Focus: Phylogenic and computational analysis of molecular evolution.
CAREER PROGRESSION
Roche Information Solutions
Innovation Lead - Santa Clara, CA (2024-present)
Contributes to the Innovation Management program, collaborating with cross-functional teams to support strategic initiatives in product development and organizational improvement. Engages with Key Opinion Leaders and customers to inform market-driven product strategies while assisting in enhancing internal processes and forward- thinking proposals.
Head of Innovation Delivery - Santa Clara, CA (2021-2024) Led the Innovation Management contribution of the development and execution of the Providers Insights Neurology for clinical use program. Fostered strong business connections with external key opinion leaders and internal cross- functional experts to support a culture of innovation. Supported the development and implementation of the innovation process to drive key results for the business. Co-led the creation and management of the program funnel management system for Innovation Management team. and is co-leading the drive for the creation of strategic insights for future Neurology funnel initiatives.
Pre-Development Program Director - Belmont, CA (2019- 2021)Drove a newly formed Pre-development program that brought structure and visibility to early stage product initiatives. Monthly meetings highlighted accomplishments and blockers of project teams to senior management in addition to enabling the opportunity for decision making by leadership on whether a project would continue. Drove the development of a population health analytics platform in collaboration with data scientists, epidemiologists, and software engineers during the COVID-19 pandemic to support an RIS COVID-19 patient software application, RDS leadership decision making, and Pharma clinical trial placements.
Project Leader - Belmont, CA (2018- 2019)
Led both a cross-functional and international team to the successful launch of two on market clinical decision support software applications to support clinical oncology teams. One application enables clinical teams to rapidly match patients with clinical trials based on their unique patient record. The second application searches for patient relevant research publications that can be used to enable patient care. Team members were located in Belmont, California, Poznan and Warsaw, Poland, and Basel, Switzerland.
Guardant Health, Inc. 2016-2017, Director, IVD Product Development
Led cross-functional project teams that developed NGS in vitro diagnostics systems. Managed the activities and performance of both direct reports and contractors involved in development projects. Delivered strategic project planning and management to in vitro diagnostic portfolio.
Roche Tissue Diagnostics 2008-2016
Project Leader - Mountain View, CA (2012- 2016)
Directed digital pathology product solutions that assist physicians and pathologists in diagnosing cancer. The technology plays a key role in enabling access to multiple pathologist consultations via the internet, quantitative tissue image analysis, and future multiplex tissue assays. Managed teams in Tucson, AZ and Mountain View, CA in the development of companion diagnostics and digital pathology imaging algorithms. Oversaw clinical trials and managed regulatory submissions for medical devices. Engaged in the development of in vitro diagnostic systems.
Supervisor, Systems Integration Tucson, AZ (2011-2012)
Provided leadership for a technical team engaged in delivering a complex technology and vendor assessment for digital pathology’s next generation hardware platform. Drove, authored and delivered feasibility plan and report that included risk assessment. Achieved design goal milestone on time and within budget.
Senior Scientist, Systems Integration, Tucson, AZ (2008-2011)
Sub-team lead for one of five modules in a tissue diagnostics platform. Spearheaded an effort to increase the reliability of the module and improve customer experience. Engaged in project management, prototype design, design execution, verification and validation testing. Conducted cross-functional communication with software engineers, hardware engineers, marketing managers, global technical support staff and key executives. Communicated and coordinated module changes, and presented final design review.
PATENTS
- “Systems and methods for predicting COVID-19 cases and deaths”, Garcia-Alcalde, F., Huang, S., Little, E., Magnus,
C., Meyer, A., Moritz, P., Wohlfart, C. WO2023198590 (2022) Pending. - “Method and system for providing interactive medical guidance”, Xie, Q., Mailman, M., Sharma, V., Nemmer, V.,
Little, E., Kaczmarek, W., Chmielarski, M., Sciurka, T., Dolt, M., Laskowski, M. US20220230763A (2019). Also
pending in Europe. - “Display screen or portion thereof with graphical user interface for interactive guidelines for multidisciplinary cancer
treatment planning”, Xie, Q., Mailman, M., Sharma, V., Nemmer, V., Little, E., Kaczmarek, W., Chmielarski, M.,
Sciurka, T., Dolt, S., Laskowski, M. USD940172S1 (2019) - “Vessel analysis in multiplexed images”, Yuan, Q., Chukka, S., Fernandez, G., Little, E., Fuchs, A. US10388014B2
(2014). Also granted in Japan, Europe, and Canada. - “Vessel analysis in multiplexed images”, Yuan, Q., Chukka, S., Fernandez, G., Little, E., Fuchs, A. US10388014B2
(2014). Also granted in Japan, Europe, and Canada. “Fluorescence Imaging System for Tissue Detection”, Bamford, P., Dietz, L., Little, E. EP3004847B1 (2013). Also granted in Australia.
PUBLICATIONS
- Barnes M, Srinivas C, Bai I, Frederick J, Liu W, Sarkar A, Wang X, Nie Y, Portier B, Kapadika M, Sertel O, Little E, Sabata B, Ranger-Moore J (2017) “Whole tumor section quantitative image analysis maximizes between-pathologists’ reproducibility for clinical immunohistorchemistry-based markers” Lab Invest. 97(12):1508-1515
- Little EJ, Dunten PW, Bitinaite J, Horton NC (2011) “New clues in the allosteric activation of DNA cleavage by SgrAI: structures of SgrAI bound to cleaved primary-site DNA and uncleaved secondary-site DNA” Acta Crystallography D Biological Crystallography 67(Pt 1):67-74.
- Park CK, Joshi HK, Agrawal A, Ghare MI, Little EJ, Dunten PW, Bitinaite J, Horton NC (2010) “Domain swapping in allosteric modulation of DNA specificity” PLoS Biol. 8(12):e1000554.
- Dunten PW, Little EJ, Horton NC (2009) “The restriction enzyme SgrAI: structure solution via combination of poor MIRAS and MR phases” Acta Crystallography D Biological Crystallography 65(Pt4):393-8.
- Little EJ, Babic AC, Horton NC (2008) “Early Interrogation and Recognition of DNA Sequence by Indirect Readout” Structure 16(12):1828-37.
- Babic AC, Little EJ, Manohar VM, Bitinaite J, Horton NC (2008) “DNA Distortion and Specificity in a Sequence Specific Endonuclease” J Mol Biol. 383(1):186-204.
- Dunten PW*, Little EJ*, Gregory MT, Manohar VM, Dalton M, Hough D, Bitinaite J, Horton NC (asterisks indicate equal contribution as first authors) (2008) “The Structure of SgrAI Bound to DNA; Recognition of an 8 Base Pair Target” Nucleic Acids Research 36(16):5406-16.
- Little EJ, Horton NC (Cover article) (2005) “DNA-induced conformational changes in type II restriction endonucleases: the structure of unliganded HincII.” J Mol Biol., 351(1):76-88.
- Weinert T, Little E, Shanks L, Admire A, Gardner R, Putnam C, Michelson R, Nyberg K, Sundareshan P (2000) “Details and concerns regarding the G2/M DNA damage checkpoint in budding yeast” Cold Spring Harb Symp Quant Biol , 65:433-41.
- Doolittle RF, Feng DF, Tsang S, Cho G, Little E (1996) “Determining divergence times of the major kingdoms of living organisms with a protein clock.” Science, 271(5248):470-7.
- Little E, Bork P, Doolittle RF (1994) “Tracing the spread of fibronectin type III domains in bacterial glycohydrolases” J Mol Evol., 39(6):631-43.